#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis gastrointestinal disease Arteriosclerosis Multiple system atrophy Keratosis follicular Advanced systemic mastocytosis Acromegaly Osteochondrodysplasia Immune-mediated enterocolitis Testicular leiomyosarcoma Hepatic angiosarcoma Bronchopulmonary aspergillosis Ventricular fibrillation Acquired haemophilia Myeloproliferative neoplasm Chronic graft versus host disease More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Basic Information Congenital hypotransferrinaemia – Diagnostics Splenic marginal zone lymphoma – Life with Disease Mantle cell lymphoma stage II Primary mediastinal large B-cell lymphoma – Diagnostics Small intestine leiomyosarcoma – Trials in Disease Haemophilia B with anti factor IX – Diagnostics Inclusion body myositis Indolent systemic mastocytosis – Trials in Disease Medulloblastoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olanzapine Protease Sodium Sulfate Anhydrous Esflurbiprofen Io103 Acetate Antipsychotics Fianlimab Naloxone Hydrochloride Clenbuterol Hydrochloride LTG-001 Bdc-1001 Misoprostol Bms-986442 Miransertib Hst-1011 Ifosfamide Prednisolone Pemetrexed Landiolol Hydrochloride Gs-5718-03 More therapies…

    Learn about Your Condition

    Papilloma viral infection Mite allergy Oesophagogastroscopy Carcinoid syndrome Fatty acid oxidation disorder Hydrocele Eosinophilic oesophagitis Oesophagectomy Pain Dermatomyositis Appendicitis perforated Tendon injury Actinic keratosis Cystic fibrosis Infantile apnoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Colmar

Centre Hospitalier De Colmar

39 Avenue De La Liberte, Bp 60535, Colmar, 68024, France

Want to learn more about this study or check if you can participate? Contact us.

  • One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    France

  • Long-term Safety Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease and History of Exacerbations

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    France

  • Study of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Epirubicin
    • Anastrozole
    • Cyclophosphamide
    France Germany Italy The Netherlands Spain

  • Study of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Ciclosporin
    • Methylprednisolone Hydrogen Succinate
    • Mycophenolic Acid
    France

  • Study on the Effects of Methylphenidate on Brain Function in Adults with ADHD, with or without Mood Disorders, Compared to Placebo

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    France

  • Study on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    • Rituximab
    France

  • Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Abiraterone
    • Apalutamide
    • Darolutamide
    Belgium Croatia Czechia Denmark France Ireland +4

  • Study on the Effectiveness of Oxybutynin for Children with Overactive Neurogenic Bladder Due to Spina Bifida

    Recruiting

    3 1 1
    Investigated Diseases:
    • Spina bifida
    Investigated Drugs:
    • OXYBUTYNIN HYDROCHLORIDE
    France

  • Study Comparing Rifabutin and Rifampicin for Adults with Staphylococcal Prosthetic Joint Infection Using DAIR Strategy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rifabutin
    • Rifampicin
    France

  • Study Comparing FOLFOX (Oxaliplatin, Fluorouracil, Calcium Folinate) to Gemcitabine for Patients with Metastatic Pancreatic Cancer Not Suitable for FOLFIRINOX

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Gemcitabine Hydrochloride
    France
1 2 3 … 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!